BioProcess Technology — The Netherlands

Topics:

• Cell Engineering
• Scale-Up
• Media and Assay Development
• Feed and Harvest Strategies
• Purification
• Safety and Regulatory Issues
• Characterization and Comparability

Applications

• Antibodies
• Recombinant Proteins
• Viral Vaccines
• Viral Gene Vectors
• Cellular Therapies

We explore the challenges faced while taking cell-derived products through development and into large-scale production. We will also touch on conducting clinical trials and setting up contract facilities.

This meeting will showcase the industry’s more successful efforts as we focus on trends in facility design and regulatory practices, plus recent advances in cell culture, analytical, and purification methods. Posters and workshops will then be used to supplement the program with details on the vital technologies and services needed for success.

• April 2-4, 2007 — Amsterdam
• March 6-8, 2006 — Barcelona, Spain
• Antibodies and Recombinant Proteins
  Viral Vectors and Vaccines
• May 22-27, 2005 — Amsterdam
• Antibodies and Recombinant Proteins
  Viral Vectors and Vaccines
• March 15-19, 2004 — Amsterdam
• Antibodies and Recombinant Proteins
  Viral Vectors and Vaccines

• April 2-4, 2007 — Amsterdam

P.O. Box 1229, Virginia Beach, VA 23451
Phone: (757) 423-8823 • Fax: (757) 423-2065 • Email:info@wilbio.com